Developed by leading researchers and clinicians from across Canada, this course will enhance knowledge and skills for patients who are using, or beginning to use, an originator or biosimilar biologic medicine.
University of Toronto
Welcome to the fascinating world of biosimilars! This intermediate-level course, offered by the University of Toronto, is designed to provide patients and caregivers with a comprehensive understanding of biosimilar medications - a rapidly growing and innovative class of biologic drugs. As biosimilars become increasingly prevalent in the global healthcare landscape, this course aims to equip you with the knowledge and skills necessary to navigate this exciting field confidently.
There are no specific prerequisites for this course. It is designed to be accessible to patients, caregivers, and anyone interested in learning about biosimilars, regardless of their prior knowledge in the field.
This course is ideal for patients who are currently using or considering biosimilar medications, caregivers supporting individuals using biosimilars, healthcare students looking to expand their knowledge, and anyone interested in learning about this innovative class of medications.
The knowledge and skills gained from this course will empower learners to:
Module 1 - Understanding Biologics and Biosimilars
Module 2 - Regulatory Approval Process
Module 3 - Patient Access
Module 4 - Discussing Biosimilars with your Health care Provider
Each module contains specific learning objectives that build upon one another, providing a comprehensive understanding of biosimilars from their basic concepts to practical applications in healthcare settings.
Explore more courses to enhance your cloud computing and Kubernetes skills.
Drugs are biologically active compounds. Drug discovery and drug development rely on methods for measuring biological activity. The term “activity” is quite general. In practice, a substance’s biological activity can refer to how a substance affects a biological pathway, cell-level responses, safety risks, how long a substance resides within in a system, as well as a substance’s effects in an organism (called pharmacodynamics). The design of methods for measuring activity is a critical aspect of drug discovery. The design of robust and informative methods can accelerate the drug discovery and development process.
Throughout this course from the Stanford Center for Health Education (SCHE), you’ll discover a range of pharmacological and nonpharmacological interventions for individuals at risk of heart disease. You’ll also learn how to improve patient engagement and outcomes.
Developed by leading researchers and clinicians from across Canada, this course will enhance knowledge and skills for clinicians who are using or beginning to use a biosimilar or biologic medicine in their professional practice setting.
